It has been reported that knockdown of p130Cas leads to proliferative arrest in breast cancer cell lines carrying oncogenic mutations in BRAF, KRAS, PTEN, or PIK3CA (Pylayeva et al., 2009). Here, BCAR1 is linked to breast carcinoma.